We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
+7.77%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$800M
AUM Growth
+$24M
Cap. Flow
+$23.2M
Cap. Flow %
2.9%
Top 10 Hldgs %
39.52%
Holding
76
New
14
Increased
22
Reduced
26
Closed
9

Top Buys

Rank Stock Value
1
APLS
Apellis Pharmaceuticals
APLS
+$25.8M
2
ABT icon
Abbott
ABT
+$21.2M
3
LLY icon
Eli Lilly
LLY
+$14M
4
CELG
Celgene Corp
CELG
+$11.6M
5
ACAD icon
Acadia Pharmaceuticals
ACAD
+$9.89M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$19M
2
MRK icon
Merck
MRK
+$12.6M
3
MOH icon
Molina Healthcare
MOH
+$12.1M
4
TSRO
TESARO, Inc.
TSRO
+$11.1M
5
ABMD
Abiomed Inc
ABMD
+$8.2M

Sector Composition

Rank Sector Weight
1 Healthcare 91.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NDRM
76
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
– –
-147,756
Closed -$5.75M
1 2 3
4

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
AAA
AG Asset Advisory Los Angeles, California $121M AUM 10.78% 1-Year Est. Return
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return

Sectoral Asset Management's Q4 2017 Portfolio in Review

As of Q4 2017, Sectoral Asset Management held 76 positions worth $800M, up 3.1% from $776M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Sectoral Asset Management's Q4 2017 filing shows 14 new, 22 increased, 26 reduced and 9 closed positions. Its largest new stake was Apellis Pharmaceuticals: 1,752,655 shares worth $38M. The largest sale was Gilead Sciences, an estimated $19M.

By sector, the portfolio is most concentrated in Healthcare at 92% of assets, down from 93% a quarter earlier.

  • Sectoral Asset Management's largest Q4 2017 buy was Apellis Pharmaceuticals: 1,752,655 shares worth $38M.
  • Sectoral Asset Management added most to Celgene Corp in Q4 2017, an estimated $11.6M increase.
  • Sectoral Asset Management's biggest Q4 2017 reduction was Merck, cutting an estimated $12.6M.
  • Sectoral Asset Management fully exited Gilead Sciences in Q4 2017, selling an estimated $19M.
  • Sectoral Asset Management's ten largest holdings make up 40% of its $800M portfolio in Q4 2017.
  • Sectoral Asset Management opened 14 new positions and closed 9 in Q4 2017.
  • Sectoral Asset Management's portfolio value rose 3.1% quarter-over-quarter to $800M.

Based on Sectoral Asset Management's 13F filing for Q4 2017, filed 13 Feb 2018.